Vivimed Labs Limited (NSE:VIVIMEDLAB)
India · Delayed Price · Currency is INR 5.55
-0.29 (-4.97%)
At close: Mar 27, 2026
Vivimed Labs Market Cap
Vivimed Labs has a market cap or net worth of 460.17 million as of March 27, 2026. Its market cap has decreased by -60.22% in one year.
Market Cap
460.17M
Enterprise Value
4.29B
Revenue
883.92M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.55
Market Cap Chart
Since August 17, 2005, Vivimed Labs's market cap has decreased from 1.04B to 460.17M, a decrease of -55.75%. That is a compound annual growth rate of -3.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 460.17M | -68.59% |
| Dec 31, 2025 | 1.47B | 61.37% |
| Dec 30, 2022 | 907.91M | -49.54% |
| Dec 31, 2021 | 1.80B | 20.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beta Drugs | 11.76B |
| Sakar Healthcare | 11.53B |
| Sigachi Industries | 6.96B |
| Valiant Laboratories | 2.91B |
| Bafna Pharmaceuticals | 2.70B |
| Nectar Lifesciences | 1.90B |
| Brooks Laboratories | 1.27B |
| Alpa Laboratories | 1.09B |